Open Access
Issue |
Med Sci (Paris)
Volume 39, Number 5, Mai 2023
|
|
---|---|---|
Page(s) | 429 - 436 | |
Section | M/S Revues | |
DOI | https://doi.org/10.1051/medsci/2023058 | |
Published online | 23 May 2023 |
- Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int 2015 ; 115 : 508–519. [CrossRef] [PubMed] [Google Scholar]
- McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003 ; 349 : 2387–2398. [CrossRef] [PubMed] [Google Scholar]
- Ploussard G, Roubaud G, Barret E, et al. French AFU Cancer Committee Guidelines - Update 2022–2024 : prostate cancer - Management of metastatic disease and castration resistance. Prog Urol 2022; 32 : 1373–419. [CrossRef] [PubMed] [Google Scholar]
- James ND, de Bono JS, Spears MR, et al. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med 2017 ; 377 : 338–351. [CrossRef] [PubMed] [Google Scholar]
- Fizazi K, Tran N, Fein L, et al. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med 2017 ; 377 : 352–360. [CrossRef] [PubMed] [Google Scholar]
- Armstrong AJ, Azad AA, Iguchi T, et al. Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol 2022; 40 : 1616–22. [CrossRef] [PubMed] [Google Scholar]
- INCa. Panorama des cancers en France. https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Panorama-des-cancers-en-France-Edition-20222022. [Google Scholar]
- Strand DW, Costa DN, Francis F, et al. Targeting phenotypic heterogeneity in benign prostatic hyperplasia. Differentiation 2017 ; 96 : 49–61. [CrossRef] [PubMed] [Google Scholar]
- Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes Dev 2000 ; 14 : 2410–2434. [CrossRef] [PubMed] [Google Scholar]
- Zhang D, Zhao S, Li X, et al. Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 2018 ; 4 : 769–783. [CrossRef] [PubMed] [Google Scholar]
- Sibony M. Pratique en anatomopathologie. La prostate. Paris : Sauramps médical, 2018 : 236p. [Google Scholar]
- Choi N, Zhang B, Zhang L, et al. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012 ; 21 : 253–265. [CrossRef] [PubMed] [Google Scholar]
- Liu J, Pascal LE, Isharwal S, et al. Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol 2011 ; 25 : 1849–1857. [CrossRef] [PubMed] [Google Scholar]
- Ousset M, Van Keymeulen A, Bouvencourt G, et al. Multipotent and unipotent progenitors contribute to prostate postnatal development. Nat Cell Biol 2012 ; 14 : 1131–1138. [CrossRef] [PubMed] [Google Scholar]
- Wang ZA, Toivanen R, Bergren SK, et al. Luminal cells are favored as the cell of origin for prostate cancer. Cell Rep 2014 ; 8 : 1339–1346. [CrossRef] [PubMed] [Google Scholar]
- Wang X, Kruithof-de Julio M, Economides KD, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009 ; 461 : 495–500. [CrossRef] [PubMed] [Google Scholar]
- Baures M, Dariane C, Tika E, et al. Prostate luminal progenitor cells : from mouse to human, from health to disease. Nat Rev Urol 2022; 19 : 201–18. [CrossRef] [PubMed] [Google Scholar]
- Mevel R, Steiner I, Mason S, et al. RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. Elife 2020; 9. [Google Scholar]
- Karthaus WR, Hofree M, Choi D, et al. Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science 2020; 368 : 497–505. [CrossRef] [PubMed] [Google Scholar]
- Crowley L, Cambuli F, Aparicio L, et al. A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors. Elife 2020; 9. [Google Scholar]
- Guo W, Li L, He J, et al. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat Genet 2020; 52 : 908–18. [CrossRef] [PubMed] [Google Scholar]
- Joseph DB, Henry GH, Malewska A, et al. Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. Prostate 2020; 80 : 872–84. [CrossRef] [PubMed] [Google Scholar]
- Baures M, Puig Lombardi E, Di Martino D, et al. Transcriptomic Signature and Growth Factor Regulation of Castration-Tolerant Prostate Luminal Progenitor Cells. Cancers (Basel) 2022; 14 : 3775. [CrossRef] [PubMed] [Google Scholar]
- Sackmann Sala L, Boutillon F, Menara G, et al. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumors. J Pathol 2017; 243 : 54–64. [Google Scholar]
- Sackmann-Sala L, Chiche A, Mosquera-Garrote N, et al. Prolactin-Induced Prostate Tumorigenesis Links Sustained Stat5 Signaling with the Amplification of Basal/Stem Cells and Emergence of Putative Luminal Progenitors. Am J Pathol 2014 ; 184 : 3105–3119. [CrossRef] [PubMed] [Google Scholar]
- Kwon OJ, Zhang L, Xin L. Stem Cell Antigen-1 Identifies a Distinct Androgen-Independent Murine Prostatic Luminal Cell Lineage with Bipotent Potential. Stem Cells 2016 ; 34 : 191–202. [CrossRef] [PubMed] [Google Scholar]
- Liu X, Grogan TR, Hieronymus H, et al. Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome. Cell Rep 2016 ; 17 : 2596–2606. [CrossRef] [PubMed] [Google Scholar]
- Joseph DB, Turco AE, Vezina CM, Strand DW. Progenitors in prostate development and disease. Dev Biol 2021; 473 : 50–8. [CrossRef] [PubMed] [Google Scholar]
- Carver BS, Chapinski C, Wongvipat J, et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 2011 ; 19 : 575–586. [CrossRef] [PubMed] [Google Scholar]
- Chan JM, Zaidi S, Love JR, et al. Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling. Science 2022; 377 : 1180–91. [CrossRef] [PubMed] [Google Scholar]
- Henry GH, Malewska A, Joseph DB, et al. A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra. Cell Rep 2018 ; 25 : 3530–42e5. [CrossRef] [PubMed] [Google Scholar]
- Rawlins EL, Okubo T, Xue Y, et al. The role of Scgb1a1+ Clara cells in the long- term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 2009 ; 4 : 525–534. [CrossRef] [PubMed] [Google Scholar]
- Hirz T, Mei S, Sarkar H, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun 2023; 14 : 663. [CrossRef] [PubMed] [Google Scholar]
- Joseph DB, Henry GH, Malewska A, et al. 5-alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia. J Pathol 2022; 256 : 427–41. [CrossRef] [PubMed] [Google Scholar]
- Song H, Weinstein HNW, Allegakoen P, et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun 2022; 13 : 141. [CrossRef] [PubMed] [Google Scholar]
- Chen S, Zhu G, Yang Y, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol 2021; 23 : 87–98. [CrossRef] [PubMed] [Google Scholar]
- Dariane C, Clairefond S, Peant B, et al. High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality. Cancers (Basel) 2022; 14 : 1623. [CrossRef] [PubMed] [Google Scholar]
- Han H, Wang Y, Curto J, et al. Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis. Cell Rep 2022; 39 : 110595. [CrossRef] [PubMed] [Google Scholar]
- Barron DA, Rowley DR. The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer 2012 ; 19 : R187–R204. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.